Loading the section…
The price of Verastem, Inc. (VSTM) on October 9, 2026 is 8.38 USD, +3.33% on the day. Over 52 weeks the stock traded between 3.43 USD and 10.82 USD; the price now sits 67% of the way up that range. Over the past year the price changed by -6.26%. Market capitalization is 736.12 million USD, rank 125 among 372 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): −9.80 %
Verastem, Inc. trades on Nasdaq under the ticker VSTM. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks VSTM has traded between 3.43 $ and 10.82 $. As of 9 October 2026 the price stood 66.98 % of the way from the 52-week low to the high.
Over one year VSTM shares fell 6.26 %; over six months they rose 57.82 %. Volatility over 90 days is 66.11 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 23.8, above the sector median of 4.0. Price to book is 9.0, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 8.12 | 8.58 | 7.98 | 8.38 | 3M |
| 8 October 2026 | 8.20 | 8.28 | 7.72 | 8.11 | 3M |
| 7 October 2026 | 7.77 | 8.36 | 7.65 | 8.27 | 4M |
| 6 October 2026 | 8.08 | 8.18 | 7.70 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Verastem, Inc. (VSTM) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2026-03-31, revenue was 30.9m $, net income was -194.0m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:117 KENDRICK STREET SUITE 500, NEEDHAM, MA, 02494, US
Verastem, Inc. reported revenue of 31M $ and a net loss of 194M $ over the last four quarters. Revenue changed by +209.14 % year over year. Earnings per share are −2.52 $. Market capitalisation is 736M $.
VSTM has a return on equity of −237.18 %, below the sector median of −41.68 %. Return on assets is −85.14 %, below the sector median of −32.11 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 7.75 |
| 3M |
| 5 October 2026 | 7.74 | 8.10 | 7.52 | 8.00 | 2M |
| 2 October 2026 | 7.95 | 8.02 | 7.52 | 7.70 | 4M |
| 1 October 2026 | 8.00 | 8.18 | 7.74 | 7.90 | 2M |
| 30 September 2026 | 7.98 | 8.40 | 7.92 | 8.05 | 2M |
| 29 September 2026 | 7.78 | 8.12 | 7.56 | 7.92 | 3M |
| 28 September 2026 | 7.59 | 7.78 | 7.39 | 7.77 | 1M |
| 25 September 2026 | 7.86 | 7.89 | 7.67 | 7.74 | 1M |
| 24 September 2026 | 8.10 | 8.20 | 7.71 | 7.80 | 2M |
| 23 September 2026 | 8.37 | 8.40 | 7.85 | 8.18 | 2M |
| 22 September 2026 | 8.04 | 8.65 | 8.00 | 8.37 | 3M |
| 21 September 2026 | 7.54 | 8.04 | 7.50 | 7.99 | 3M |
| 18 September 2026 | 7.58 | 7.84 | 7.40 | 7.44 | 4M |
| 17 September 2026 | 7.58 | 7.91 | 7.54 | 7.55 | 2M |
| 16 September 2026 | 7.35 | 7.41 | 7.20 | 7.32 | 1M |
| 15 September 2026 | 7.48 | 7.52 | 7.25 | 7.34 | 3M |
| 14 September 2026 | 7.36 | 7.62 | 7.25 | 7.51 | 2M |